Evidence map›Paper›PMID 42352551›Full record

ArticleCancers2026

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Eline G M Steenhuis, Lieke M van Disseldorp, Femke J C Jacobs, Nathalie van Schayk, Karijn Suijkerbuijk, Marieke Louwman, Julia N S d'Hooghe, Ronald A M Damhuis, Wouter H van Geffen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eline G M SteenhuisDepartment of Pulmonology, Isala, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands.ORCID 0000-0001-9214-958X
Lieke M van DisseldorpDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Rijnkade 5, 3511 LC Utrecht, The Netherlands.ORCID 0009-0009-8345-8802
Femke J C JacobsDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Rijnkade 5, 3511 LC Utrecht, The Netherlands.ORCID 0009-0006-5631-9629
Nathalie van SchaykDepartment of Information and Advice, Netherlands Comprehensive Cancer Organisation (IKNL), Rijnkade 5, 3511 LC Utrecht, The Netherlands.
Karijn SuijkerbuijkDepartment of Oncology, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.ORCID 0000-0003-3604-5430
Marieke LouwmanDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Rijnkade 5, 3511 LC Utrecht, The Netherlands.
Julia N S d'HoogheDepartment of Pulmonology, Onze Lieve Vrouwen Gasthuis, Oosterpark 9, 1091 AC Amsterdam, The Netherlands.
Ronald A M DamhuisDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Rijnkade 5, 3511 LC Utrecht, The Netherlands.
Wouter H van GeffenDepartment of Pulmonology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-5976-0974

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

elderlyimmunotherapymelanomaNSCLC

Identifiers

PMID42352551
PMCPMC13297090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.